alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Mystica Candle Corp. (the "Company")
on Form 10-QSB for the period ending December 31, 2005 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Candace
Sikorski, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
9th day of February, 2006.


/s/ Candace Sikorski
------------------------------
Chief Financial Officer
EXHIBIT 35.1

SERVICER COMPLIANCE STATEMENT

American Express Travel Related Services Company, Inc.

American Express Credit Account Master Trust

Reporting Period January 1, 2013 to December 31, 2013

The undersigned, a duly authorized representative of American Express Travel Related Services Company, Inc. (TRS), as Servicer pursuant to the
American Express Credit Account Master Trust (the Trust) Pooling and Servicing Agreement, dated as of May 16, 1996, as amended and restated as of January 1, 2006, as amended by the First Amendment to the Pooling and Servicing
Agreement, dated as of December 17, 2007, as amended by the Second Amendment to the Pooling and Servicing Agreement, dated as of October 24, 2008, as amended by the Third Amendment to the Pooling and Servicing Agreement, dated as of
February 24, 2009, as amended by the Fourth Amendment to the Pooling and Servicing Agreement, dated as of October 7, 2010, and as amended by the Fifth Amendment to the Pooling and Servicing Agreement, dated as of May 10, 2013 (as so
amended and restated and as otherwise amended from time to time, the Agreement), among American Express Receivables Financing Corporation II, American Express Receivables Financing Corporation III LLC, and American Express Receivables
Financing Corporation IV LLC, as transferors, TRS, as servicer (in such capacity, the Servicer), and The Bank of New York Mellon (formerly The Bank of New York), as trustee and securities intermediary (the Trustee), does
hereby certify that:



|1. | TRS is Servicer under the Agreement.
|-- | ------------------------------------



|2. | The undersigned is duly authorized as required pursuant to the Agreement to execute and deliver this Certificate.
|-- | -----------------------------------------------------------------------------------------------------------------



|3. | A review of the Servicers activities during the reporting period and of its performance under the Agreement has been made under my supervision.
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------



|4. | To the best of my knowledge, based on such review, the Servicer has fulfilled all of its obligations under the Agreement in all material respects throughout the reporting period.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

IN WITNESS WHEREOF, the undersigned has duly executed this Certificate this 20th day of March, 2014.



|                                                       |  |                
|------------------------------------------------------ |  | ---------------
|AMERICAN EXPRESS TRAVEL RELATED SERVICES COMPANY, INC.
|                                                       | 
|By:                                                    |  | /s/ Kanchan Roy
|Name:                                                  |  | Kanchan Roy    
|Title:                                                 |  | Vice President
# L_2015277EN.01006101.xml

| 22.10.2015 | EN | Official Journal of the European Union | L 277/61 |
| --- | --- | --- | --- |

22.10.2015

EN

Official Journal of the European Union

L 277/61

---

Corrigendum to Regulation (EC) No 1013/2006 of the European Parliament and of the Council of 14 June 2006 on shipments of waste

(
  Official Journal of the European Union L 190 of 12 July 2006
  )

On page 59, Annex V, Part 1, code A4110, second indent:

for:

| ‘— | any congenor of polychlorinated dibenzo-dioxin’, |
| --- | --- |

‘—

read:

| ‘— | any congenor of polychlorinated dibenzo-p-dioxin’; |
| --- | --- |

‘—

on page 60, Annex V, Part 1, code B1080:

for:

| ‘B1080 | Zinc ash and residues including zinc alloys residues in dispersible form unless containing Annex I constituents in concentration such as to exhibit Annex III characteristics or exhibiting hazard characteristic H4.3 (2)’, |
| --- | --- |

‘B1080

Zinc ash and residues including zinc alloys residues in dispersible form unless containing Annex I constituents in concentration such as to exhibit Annex III characteristics or exhibiting hazard characteristic H4.3 (2)’,

read:

| ‘B1080 | Zinc ash and residues including zinc alloys residues in dispersible form unless containing Annex I constituents in concentration such as to exhibit Annex III characteristics (2)’; |
| --- | --- |

‘B1080

Zinc ash and residues including zinc alloys residues in dispersible form unless containing Annex I constituents in concentration such as to exhibit Annex III characteristics (2)’;

on page 61, Annex V, Part 1, code B1120, second indent, second column:

for:

‘Neodym’,

read:

‘Neodymium’;

on page 63, Annex V, Part 1, code B2060:

for:

‘...not containing any Annex I constituents to an extent they exhibit...’,

read:

‘...not containing any Annex I constituents to the extent that they exhibit...’;

on page 66, Annex V, Part 1, code B3060, third indent:

for:

| ‘— | Degras: residues resulting ...’, |
| --- | --- |

‘—

read:

| ‘— | Degras; residues resulting ...’; |
| --- | --- |

‘—

on page 66, Annex V, Part 1, code B4020:

for:

‘... e.g. water based, or glues based on casein starch, dextrin, cellulose ethers, ...’,

read:

‘... e.g. water-based, or glues based on casein, starch, dextrin, cellulose ethers, ...’.

---
ADDENDUM TO
                    PURCHASE AGREEMENT - DATED MARCH 1, 2001

This  Agreement  (the  "Addendum"),  effective  October  15,  2002,  between CFC
International,   a  Delaware   corporation,   ("CFC"),   and  Baxter  Healthcare
Corporation, a Delaware corporation, and its successors,  affiliates and assigns
("Baxter"),   amends  the  Purchase  Agreement  ("Agreement")  between  the  two
companies dated March 1, 2001.

1.  General Provisions
----------------------

All "terms and  conditions" of the original  Agreement will remain  effective as
stated in the Agreement with only the specific  revisions as stated below.  This
addendum applies to CFC products B10EK black and B5603AB black.

2.0  Distribution
-----------------

Buyer agrees to purchase foil  requirements for current users,  which are wholly
owned  subsidiaries  of Baxter  Healthcare  Corporation.  Other locations can be
added by mutual agreement of both parties.

3.0  Shipment of Products
-------------------------

Seller will ship  Products  F.O.B.  Seller's  manufacturing  facilities - either
Chicago Heights, IL. USA or Goppingen, Germany.

4.0  Price for Products
-----------------------

CFC will reduce the cost structure of black B10EK and black B5603AB as stated in
Exhibit 1 (new price list). Products shipped from Chicago Heights will be billed
in U.S. dollars; products shipped from Germany will be billed in Euros.

10.0  Term
----------

The addendum will extend the contract until February 28, 2007.

13.0  Other Provisions
----------------------

Section 13.2 is deleted for B10EK and B5603AB.


Baxter Healthcare Corporation               CFC International, Inc.

---------------------------                  ---------------------------
Dave Valentini                               Greg M. Jehlik
Vice President, Purchasing/Supplier          President & Chief Operating Officer
Management
Date:                                         Date:

----------------------------
Mike Gatling
Corporate Vice President, Global
Manufacturing Operations
Date:

----------------------------
Maria Johnson
Vice President of Operations,
Intercontinental
Date:
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 1847 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 1847

  To modify and extend the suspension of duty on clodinafop-propargyl.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 22, 2009

 Mr. Nelson of Nebraska introduced the following bill; which was read 
             twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To modify and extend the suspension of duty on clodinafop-propargyl.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CLODINAFOP-PROPARGYL.

    (a) In General.--Heading 9902.12.55 of the Harmonized Tariff 
Schedule of the United States (relating to clodinafop-propargyl) is 
amended--
            (1) by striking ``1.7%'' and inserting ``3.9%''; and
            (2) by striking the date in the effective period column and 
        inserting ``12/31/2011''.
    (b) Effective Date.--The amendments made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
#### The People of the State of New York, Respondent, v David Jordan, Appellant.

Judgment, Supreme Court, New York County (Alfred Kleinman, J.), rendered February 26, 1988, convicting defendant, after jury trial, of grand larceny in the fourth degree, and sentencing him, as a second felony offender, to two to four years imprisonment, and order of the same court (Alfred Kleinman, J.) entered April 24, 1990, denying defendant’s motion to vacate his conviction, unanimously affirmed.

Defendant’s conviction arises out of his arrest for the robbery of Lily Jung’s purse on a Manhattan subway train during the evening rush hour of January 23, 1987.

We reject defendant’s claim of ineffective assistance of counsel. The record indicates that trial counsel made appropriate pre-trial and trial motions, conducted extensive cross-examination of the People’s witnesses, vigorously pursued a *330misidentification defense, and understandably did not request an alibi charge on the basis of defendant’s brief and contradictory testimony, elicited only upon cross-examination, that he was, and was not, in New York City on the date in question. Defense counsel’s partially successful trial strategy, which resulted in defendant’s acquittal on the charge of robbery in the third degree, but conviction on the lesser charge of grand larceny in the fourth degree, is not an indication of ineffective assistance of counsel *(see, People v Baldi,*54 NY2d 137).

As the prosecutor’s summation constituted fair comment on the evidence *(People v Fielding,*158 NY 542), and appropriate response to the defense summation *(see, e.g., People v Marks,*6 NY2d 67, *cert denied*362 US 912), there is no ground for defendant’s claim that his counsel erred by not objecting to the prosecutor’s summation comments.

Finally, the record does not support defendant’s claim that the prosecutor violated the trial court’s *Sandoval*ruling, and there is no evidence that the trial court abused its discretion either in making its ruling, or in defining the scope of cross-examination regarding defendant’s prior convictions *(see, e.g., People v Bennette,*56 NY2d 142). Concur—Carro, J. P., Milonas, Rosenberger and Kupferman, JJ.
# Capstone comments to EPA Well Completion and Associ ated Gas Methane Reduction White Paper

Please find attached a response from Capstone Turbi ne to the white paper "Oil and Natural Gas Sector H ydraulically Fractured Oil Well Completions and Associated Gas d uring Ongoing Production." Thank you for the opport unity to comment. Bryan Stockton | Director of Government Relations ML Strategies, LLC 701 Pennsylvania Ave., NW, Suite 900 | Washington, DC 20004 Direct: (202) 434­7480 | Fax: (202) 434­7400 E­mail: Bstockton@mlstrategies.com Web: www.mlstrategies.com https://mint zmail.mint A Consulting Affiliate of Mintz Levin



## Bryan <Bstockton@mlstrategies.com> Stockton, Fri 6/13/2014 4:48 PM
To: OilandGas.Whitepapers <OilandGas.Whitepapers@epa.go v>; Cc: Jen Derstine <jderstine@capstoneturbine.com>; 

###  1 attachment Capstone EPA Well Completion Methane Reduction Whit e Paper comments.pdf; 

### Page **1 of**  **1 Capstone comments to EPA Well Completion and Associ...** 
**- OilandGas.Whitepapers** 

**8/ 26/** **2014 https://pod51045.outlook.com/owa/OilandGas.Whitepapers@epa.gov/**
EXHIBIT
99.4



WRITTEN STATEMENT

PURSUANT TO

18
U.S.C. SECTION 1350



The undersigned, Abdo H.
Khoury, the Chief Financial Officer, of ARV Assisted Living, Inc. (the Company), pursuant to 18 U.S.C. §1350, hereby certifies that:



(i)    the annual Form 10K of the Company (the Report) fully complies with the requirements of
section 13(a) and 15(d) of the Securities Exchange Act of 1934; and



(ii)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|Dated: March 27, 2003 |  |  |  | 
|--------------------- |  |  |  | 
|                     
|                      |  |  |  | 
|                      |  |  |  |
May 22, 2018

JUDGMENT

The Fourteenth Court of Appeals

JESUS AVALOS AND MARIA AVALOS, Appellants

NO. 14-18-00047-CV V.

SEAWAY CRUDE PIPELINE COMPANY LLC, Appellee

________________________________

Today the Court heard appellants’ motion to dismiss the appeal from the 

judgment signed by the court below on October 24, 2017. Having considered the 

motion and found it meritorious, we order the appeal DISMISSED.

We further order that appellants shall pay the costs appellants incurred and 

appellee shall pay the costs it incurred by reason of this appeal.

We further order that mandate be issued immediately.

We further order this decision certified below for observance.
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

LIU ZHU ZHANG,

 Petitioner,

 v.

LORETTA E. LYNCH, Attorney General,

 Respondent.

No. 13-73597

Agency No. A088-103-903

MEMORANDUM*

On Petition for Review of an Order of the

Board of Immigration Appeals

Submitted May 24, 2016**

Before: REINHARDT, W. FLETCHER, and OWENS, Circuit Judges.

Liu Zhu Zhang, a native and citizen of China, petitions for review of the 

Board of Immigration Appeals’ (“BIA”) order dismissing his appeal from an 

immigration judge’s decision denying his application for asylum, withholding of 

removal, and protection under the Convention Against Torture (“CAT”). We 

 

* This disposition is not appropriate for publication and is not precedent 

except as provided by Ninth Circuit Rule 36-3.

** The panel unanimously concludes this case is suitable for decision 

without oral argument. See Fed. R. App. P. 34(a)(2).

FILED

JUN 6 2016

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
 2 

have jurisdiction under 8 U.S.C. § 1252. We review for substantial evidence the 

agency’s factual findings, applying the standards governing adverse credibility 

determinations created by the REAL ID Act. Shrestha v. Holder, 590 F.3d 1034, 

1039-40 (9th Cir. 2010). We deny the petition for review.

Substantial evidence supports the BIA’s adverse credibility determination 

based on inconsistencies in Zhang’s testimony regarding his house church 

attendance in China, inconsistencies between his testimony and documentary 

evidence regarding his church attendance in the United States, and his nonresponsive and evasive demeanor. See id. at 1048 (adverse credibility finding 

reasonable under the totality of the circumstances). In the absence of credible 

testimony, Zhang’s asylum and withholding of removal claims fail. See Farah v. 

Ashcroft, 348 F.3d 1153, 1156 (9th Cir. 2003).

Finally, Zhang’s CAT claim fails because it is based on the same evidence

that was found not credible, and the record does not otherwise compel the 

conclusion that it is more likely than not he will be tortured by or with consent or 

acquiescence of the Chinese government. See id. at 1156-57.

PETITION FOR REVIEW DENIED.
II 

111TH CONGRESS 

1ST SESSION S. 2242 

To suspend temporarily the duty on certain sardines in oil, in airtight 

containers, neither skinned nor boned. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 29, 2009 

Mrs. FEINSTEIN introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To suspend temporarily the duty on certain sardines in oil, 

in airtight containers, neither skinned nor boned. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CERTAIN SARDINES IN AIRTIGHT CONTAINERS. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 Sardines, in oil, in airtight 

containers, neither skinned 

nor boned (provided for in 

subheading 1604.13.20) ........ Free No change No change On or before 

12/31/2011 ’’. 


wwoods2 on DSK1DXX6B1PROD with BILLS
2 

•S 2242 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to goods entered, or withdrawn from 

3 warehouse for consumption, on or after the 15th day after 

4 the date of enactment of this Act. 

Æ 


wwoods2 on DSK1DXX6B1PROD with BILLS
#### In the Matter of the Claim of Phylies Wolfbiss, Appellant. Thomas F. Hartnett, as Commissioner of Labor, Respondent.

Appeal from a decision of the Unemployment Insurance Appeal Board, filed June 27, 1990, which ruled that claimant was disqualified from receiving unemployment insurance benefits because she voluntarily left her employment without good cause.

Claimant contends that she left her employment because her employer singled her out and harassed and humiliated her, causing her physical and mental strain and stress. Not only does the evidence fail to support this assertion, but it has been held that failure to get along with one’s boss does not constitute good cause for leaving one’s employment *(see, Matter of Grossman [Levine],*51 AD2d 853; *Matter of Snapperman [Levine],*50 AD2d 1029). In addition, while claimant contends that the problems with her employer caused her stress, it is significant to note that she remained on the job for several months after an alleged incident occurred and she received no medical advice to leave her job *(see, Matter of Chawkin [Catherwood],*18 AD2d 750). Under the circumstances, the Unemployment Insurance Appeal Board’s determination that *1048claimant left her employment for personal and noncompelling reasons is supported by substantial evidence *(see, Matter of Logan [Levine],*52 AD2d 679, *lv denied*39 NY2d 709).

Decision affirmed, without costs. Weiss, J. P., Yesawich, Jr., Levine, Mercure and Harvey, JJ., concur.
II 

111TH CONGRESS 

1ST SESSION S. 2323 

To extend the temporary suspension of duty on aqueous dispersions of 

poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate) (cationic), whether or not containing binder resin and organic solvent. 

IN THE SENATE OF THE UNITED STATES 

OCTOBER 29, 2009 

Mr. KERRY (for himself, Mr. KIRK, and Mr. GRAHAM) introduced the 

following bill; which was read twice and referred to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on aqueous 

dispersions of poly(3,4-ethylenedioxythiophene) 

poly(styrenesulfonate) (cationic), whether or not containing binder resin and organic solvent. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


hsrobinson on DSK69SOYB1PROD with BILLS
2 

•S 2323 IS

1 SECTION 1. AQUEOUS DISPERSIONS OF POLY(3,4- 

2 ETHYLENEDIOXYTHIOPHENE) 

3 POLY(STYRENESULFONATE) (CATIONIC), 

4 WHETHER OR NOT CONTAINING BINDER 

5 RESIN AND ORGANIC SOLVENT. 

6 (a) IN GENERAL.—Heading 9902.39.15 of the Har7 monized Tariff Schedule of the United States (relating to 

8 aqueous dispersions of poly(3,4-ethylenedioxythiophene) 

9 poly(styrenesulfonate) (cationic), whether or not con10 taining binder resin and organic solvent) is amended by 

11 striking the date in the effective period column and insert12 ing ‘‘12/31/2011’’. 

13 (b) EFFECTIVE DATE.—The amendment made by 

14 subsection (a) applies to goods entered, or withdrawn from 

15 warehouse for consumption, on or after the 15th day after 

16 the date of the enactment of this Act. 

Æ 


hsrobinson on DSK69SOYB1PROD with BILLS
# Third District Court of Appeal State of Florida
Opinion filed March 16, 2022

. Not final until disposition of timely filed motion for rehearing.

________________ No. 3D 2 1

- 331 Lower Tribunal No s

. 1 3

- 1 0056 S P & 20

- 2 79 AP

________________ United Automobile Insurance Company , Appellant,

vs. Millennium Radiology, LLC d/b/a Millennium Open MRI, a/a/o William Thonday , Appellee.
An Appeal from the C ounty Court for Miami

- Dade County, Ayana Harris , Judge. Michael J. Neimand , for appellant

. David B. Pakula, P.A., and David B. Pakula (Pembroke Pines); Marks & Fleischer, P.A., and Gary Marks (Fort Lauderdale) , for appellee.

Before SCAL ES , H E NDON and MIL L E R , JJ. PER CURIAM

.2 Appellant United Automobile Insurance Company, an insurer, challenges a final summary judgment in favor of Millennium Radiology, LLC, a medical provider and assignee of the insured, William Thonday, in a first

party per sonal injury protection action. Below, United Auto disputed the reasonableness of Millennium Radiology’s charge for an MRI procedure . The trial court granted summary judgment to Millennium Radiology on the basis of collateral estoppel, finding
that in a prior PIP lawsuit between the parties, a jury had made the determination that the amount charged for the MRI procedure was reasonable. On appeal, United Auto argues that the parties in the respective
lawsuits are not identical because Millen nium Radiology received assignment from different insureds , and thus, the “identity” element of the collateral estoppel doctrine is not satisfied. We recently decided this issue in United Automobile Insurance Co. v. Millennium Radiology , 47 Fla. L. Weekly D175, 2022 WL 107604 at *3 (Fla. 3d DCA Jan. 12, 2022) , where we held that Millennium Radiology’s identity is not the same from case to case, as it draws its identity from the insured, its assignor. We recognize that the trial court did not have the benefit of this

o pinion at the time it entered judgment in the instant case; nevertheless, we3 reverse the final summary judgment because the identity of the parties did not exist to warrant the application of collateral estoppel.
Reversed and remanded

.
-86 -84 -82 -80 -78 -76 -74
36 38 40 42 

### ★

▲ ▲ ▲ ▲



### ★ ▲ ▲ ▲ ▲ 500 1000 1500 1000 18 12 06 00 07/10 

### NOAA HYSPLIT MODEL 

## Backward trajectory ending at 2300 UTC 10 Jul 06

EDAS Meteorological DataSource★at 39.56 N 76.20 WMeters AGL